Chemed Corp. (CHE)
NYSEHealth CareMedical - Care FacilitiesSnapshot 2026-11-04
$533.77-2.71%
Close 2026-11-05 · 1-day change
NYSEHealth CareMedical - Care FacilitiesSnapshot 2026-11-04
QuarterlyIQ Insights · CHE
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 13.0% |
| Our one-year growth estimate | diamond | 8.2% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 4.8 percentage points more one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-04 · Compared with 12 industry peers · Company calendar date is not available
CHE — credit agreement
Dated 2026-04-13
ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT On April 10, 2026, Chemed Corporation (“Chemed” or "we") renewed our $450 million senior secured credit facilities (“Credit Facilities”). JPMorgan Chase Bank, N.A., acted as the Administrative Agent, Joint Lead Arranger and Joint Bookrunner. Bank of America, N.A., acted as Joint Lead Arranger, Joint Bookrunner and Syndication Agent. PNC Bank, N.A. and U.S. Bank, N.A. were Co-Documentation Agents. Terms of the Credit Facilities consist of a five-year…
Why it matters: Chemed said results through Q3 put adjusted EPS at or slightly above its prior high end. The year-end report will test that update.
Supportive ifChemed reports 2026 adjusted EPS of at least $25.75, the high end of its Q2 guidance.
Worry ifChemed reports 2026 adjusted EPS below $25.00, the low end of its Q2 guidance.
Why it matters: VITAS growth lifted Chemed's full-year outlook. Census growth tests whether that pace can continue.
Supportive ifVITAS reports 2026 average daily census growth at or above 4.5%, the low end of its revised range.
Worry ifVITAS reports average daily census growth below 4.5% in 2026.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$80 on $10,000 · ±0.8% | How much price usually moves either way. |
| Bad day | $221 loss on $10,000 · 2.2% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $2,298 loss on $10,000 · 23.0% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.